Related Experiment Video
Updated: Feb 13, 2026

In Situ Visualization of Axon Growth and Growth Cone Dynamics in Acute Ex Vivo Embryonic Brain Slice Cultures
Published on: October 14, 2021
Association of Growth Hormone Adherence and Growth Outcomes in Paediatric Patients: Results From a Clinical Registry
Tilman Robert Rohrer1, Klaus Hartmann2, Peter Herbert Kann3
1Department of General Pediatrics and Neonatology, Saarland University Medical Center, Homburg, Germany.
Insights
High adherence to daily growth hormone (GH) therapy significantly improves growth outcomes in children with growth disorders. Maintaining at least 85% adherence leads to better height standard deviation score changes over two years.
Area of Science:
- Pediatric endocrinology
- Growth disorders
- Pharmacological adherence
Background:
- Daily growth hormone (GH) therapy is crucial for managing pediatric growth disorders.
- Long-term patient adherence is essential for treatment efficacy.
- Understanding the impact of adherence on growth outcomes is vital.
Purpose of the Study:
- To investigate the association between adherence to daily GH therapy and 2-year growth outcomes.
- To analyze growth improvements in pediatric patients with growth disorders based on adherence levels.
- To identify optimal adherence thresholds for maximizing growth response.
Main Methods:
- Retrospective cohort study design.
- Categorization of patients into low (<85%), high (85%-110%), and >110% adherence groups after 2 years of GH treatment.
- Analysis of change in height standard deviation score (ΔHSDS) using Spearman's rank correlation and general linear regression.
Main Results:
- Seventy-four pediatric patients were analyzed.
- High adherence (≥85%) was significantly positively correlated with ΔHSDS (rs=0.33, p<0.01).
- High adherence group showed a mean ΔHSDS of 0.87, compared to 0.33 in the low adherence group, with an estimated improvement of 0.44 (p=0.03).
Conclusions:
- Sustained high adherence (≥85%) to daily GH therapy is associated with clinically meaningful growth improvement over 2 years.
- Adherence levels directly impact the effectiveness of GH therapy in pediatric patients.
- Achieving and maintaining high adherence is critical for optimizing growth outcomes in children with growth disorders.
Objective:
Daily growth hormone (GH) therapy for growth disorders requires long-term adherence. The aim of this study was to investigate the association of adherence with 2-year growth outcomes in paediatric patients receiving daily GH therapy in a clinical registry.
Design:
Retrospective cohort study.
Patients:
Patients with growth disorder were categorized after 2 years of treatment into low adherence (< 85%), high adherence (85%-110%) and adherence > 110% groups. Only patients with consistent adherence classification across both years were included in the 2-year outcome analysis.
Measurements:
Growth outcomes were compared the change in height standard deviation score (ΔHSDS) over 2 years. Statistical tests were performed using the nonparametric Spearman's rank correlation coefficient and a general linear regression model.
Results:
Seventy-four patients were analysed after 2 years of treatment. Mean ΔHSDS was 0.87 in the high adherence group and 0.33 in the low adherence group (absolute difference 0.54). Using the Spearman's correlation coefficient, ΔHSDS was statistically significantly positively correlated with high adherence compared to low adherence (rs = 0.33; p < 0.01). The linear regression results support these findings and estimate an improved ΔHSDS of 0.44 for patients in the high adherence group compared to the low adherence group (p = 0.03). Mean ΔHSDS in the adherence > 110% group was 0.79.
Conclusion:
Sustained high adherence (≥ 85%) to daily GH therapy was associated with clinically meaningful improvement in growth over 2 years.
More Related Videos
05:56Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts
Published on: January 22, 2020
09:28Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
Related Concept Videos
Population Growth
Primary and Secondary Growth in Roots and Shoots
Meristems and Plant Growth
Relationship Growth
Exponential Growth
Plant Hormones